BIG PHARMAS, NOT SUCH AN ALL-WEATHER INVESTMENT
25/06/20 -"This story was first issued on 15-06-2020. ‘Valuation Wise’ takes a rest. Pre-COVID-19, holding Big Pharmas (seven issuers, €940bn market cap) would not make a big difference ..."
Pages
64
Language
English
Published on
25/06/20
You may also be interested by these reports :
20/11/25
Interestingly, European Banks did not escape the last 5 trading days (to 18-11 close) market correction, as doubts surfaced about AI’s lack of a ...
19/11/25
Credit Agricole unveiled an ambitious 2025-28 plan targeting >14% ROTE and >€8.5bn net income, implying 14–16% RoCET1 depending on the use of its ...
17/11/25
As its name suggests, Swiss Life (REDUCE ; Switzerland) focuses on pensions and savings – it is in fact one of the few pure (or almost pure) plays in ...
13/11/25
KBC delivered another quarter of accelerating earnings momentum, with upgrades to 2025 guidance supported by broad-based growth, strict cost control, ...